ICE vs TGTX · P/E 37, rev $7.28B vs P/E 18, rev $240.3M
Intercontinental Exchange Inc (ICE) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported ICE revenue for 2026-06-30 was $7.28B. Net income was $2.37B. Revenue was up 98.5% from 2026-03-31 to 2026-06-30. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
ICE currently screens at market cap $103.55B and trailing P/E 37.3. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the ICE and TGTX stock pages for the full models.
Not investment advice.